NCT00562965 2018-01-09Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)PfizerPhase 3 Terminated29 enrolled 14 charts
NCT00060684 2015-01-19Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's LymphomaCTI BioPharmaPhase 1 Completed30 enrolled